0001104659-23-114405.txt : 20231103 0001104659-23-114405.hdr.sgml : 20231103 20231103200914 ACCESSION NUMBER: 0001104659-23-114405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZACCARDELLI DAVID CENTRAL INDEX KEY: 0001627642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 231377856 MAIL ADDRESS: STREET 1: 300 TRI STATE INTERNATIONAL STREET 2: SUITE 272 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm2329834-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-11-01 0 0001657312 Verona Pharma plc VRNA 0001627642 ZACCARDELLI DAVID 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 1 1 0 0 President and CEO 0 Ordinary Shares 2023-11-01 4 F 0 809008 1.7438 D 16422792 D Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units. The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2023 divided by eight (8). Consists of (i) 4,655,928 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 581,991 ADSs); and (ii) 11,766,864 Ordinary Shares underlying 1,470,858 ADSs. /s/ Claire Poll, Attorney-in-fact for David Zaccardelli 2023-11-03